Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism
Condition: Pulmonary Embolism Interventions: Drug: Tissue Plasminogen Activator, Alteplase; Drug: Low-molecular weight heparin Sponsor: Ege University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials